XXIX METAL CORP (XXIX.CA) Fundamental Analysis & Valuation

TSX-V:XXIX • CA9013201012

Current stock price

0.11 CAD
-0.01 (-4.35%)
Last:

This XXIX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XXIX.CA Profitability Analysis

1.1 Basic Checks

  • XXIX had negative earnings in the past year.
  • XXIX had a negative operating cash flow in the past year.
  • In multiple years XXIX reported negative net income over the last 5 years.
  • In the past 5 years XXIX always reported negative operating cash flow.
XXIX.CA Yearly Net Income VS EBIT VS OCF VS FCFXXIX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • XXIX has a worse Return On Assets (-301.30%) than 84.84% of its industry peers.
  • Looking at the Return On Equity, with a value of -606.86%, XXIX is doing worse than 74.81% of the companies in the same industry.
Industry RankSector Rank
ROA -301.3%
ROE -606.86%
ROIC N/A
ROA(3y)-94.2%
ROA(5y)-37.77%
ROE(3y)-97.87%
ROE(5y)-38.15%
ROIC(3y)N/A
ROIC(5y)N/A
XXIX.CA Yearly ROA, ROE, ROICXXIX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for XXIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XXIX.CA Yearly Profit, Operating, Gross MarginsXXIX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

5

2. XXIX.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for XXIX has been increased compared to 1 year ago.
  • XXIX has more shares outstanding than it did 5 years ago.
  • XXIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
XXIX.CA Yearly Shares OutstandingXXIX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XXIX.CA Yearly Total Debt VS Total AssetsXXIX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • XXIX has an Altman-Z score of -6.44. This is a bad value and indicates that XXIX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -6.44, XXIX is not doing good in the industry: 70.18% of the companies in the same industry are doing better.
  • There is no outstanding debt for XXIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.44
ROIC/WACCN/A
WACCN/A
XXIX.CA Yearly LT Debt VS Equity VS FCFXXIX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that XXIX should not have too much problems paying its short term obligations.
  • XXIX has a Current ratio of 1.88. This is comparable to the rest of the industry: XXIX outperforms 49.50% of its industry peers.
  • XXIX has a Quick Ratio of 1.88. This is a normal value and indicates that XXIX is financially healthy and should not expect problems in meeting its short term obligations.
  • XXIX has a Quick ratio of 1.88. This is comparable to the rest of the industry: XXIX outperforms 51.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
XXIX.CA Yearly Current Assets VS Current LiabilitesXXIX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. XXIX.CA Growth Analysis

3.1 Past

  • XXIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.25%.
EPS 1Y (TTM)-220.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 17.89% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.48%
EPS Next 2Y28.01%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XXIX.CA Yearly EPS VS EstimatesXXIX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06

0

4. XXIX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XXIX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XXIX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XXIX.CA Price Earnings VS Forward Price EarningsXXIX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XXIX.CA Per share dataXXIX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06

4.3 Compensation for Growth

  • XXIX's earnings are expected to grow with 17.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.01%
EPS Next 3Y17.89%

0

5. XXIX.CA Dividend Analysis

5.1 Amount

  • No dividends for XXIX!.
Industry RankSector Rank
Dividend Yield 0%

XXIX.CA Fundamentals: All Metrics, Ratios and Statistics

XXIX METAL CORP

TSX-V:XXIX (4/7/2026, 7:00:00 PM)

0.11

-0.01 (-4.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.45%
Inst Owner ChangeN/A
Ins Owners1.76%
Ins Owner ChangeN/A
Market Cap42.09M
Revenue(TTM)N/A
Net Income(TTM)-17.21M
Analysts80
Price Target0.41 (272.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.84
P/tB 14.84
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -301.3%
ROE -606.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-94.2%
ROA(5y)-37.77%
ROE(3y)-97.87%
ROE(5y)-38.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1661.04%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z -6.44
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.64%
EPS Next Y-26.48%
EPS Next 2Y28.01%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-428.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-232.91%
EBIT Next 3Y-15.99%
EBIT Next 5YN/A
FCF growth 1Y46.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.5%
OCF growth 3YN/A
OCF growth 5YN/A

XXIX METAL CORP / XXIX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XXIX METAL CORP (XXIX.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to XXIX.CA.


Can you provide the valuation status for XXIX METAL CORP?

ChartMill assigns a valuation rating of 0 / 10 to XXIX METAL CORP (XXIX.CA). This can be considered as Overvalued.


What is the profitability of XXIX stock?

XXIX METAL CORP (XXIX.CA) has a profitability rating of 0 / 10.


What is the financial health of XXIX METAL CORP (XXIX.CA) stock?

The financial health rating of XXIX METAL CORP (XXIX.CA) is 5 / 10.